Corporate

Apr, 2016

News / Corporate

Apr 06, 2016

Astellas Appoints Joseph Fleishaker to Lead Clinical Pharmacology and Exploratory Development

Astellas recently announced that Joseph Fleishaker, Ph.D., has been named vice president, Clinical Pharmacology and Exploratory Development. Fleishaker will be located at Astellas' global...

Mar, 2016

News / Corporate

Mar 10, 2016

Astellas Nominates Fellows to Leadership Council on Legal Diversity

Astellas, an active member of the Leadership Council on Legal Diversity (LCLD) since 2014, has nominated Katie Leaman, assistant general counsel, regulatory, and David Cole, senior corporate...

Feb, 2016

News / Corporate

Feb 10, 2016

Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries

Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") announced today that it has successfully completed, through its indirect wholly-owned subsidiary Laurel...

Jan, 2016

News / Corporate

Jan 29, 2016

Astellas Announces Financial Results for Q3 FY2015

Please click here for more details. About Astellas Astellas is a pharmaceutical company dedicated to improving the health of people around the world through provision of innovative and reliable...

News / Corporate

Jan 22, 2016

Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics

Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Ocata Therapeutics, Inc. (NASDAQ: OCAT, President and CEO: Paul Wotton, "Ocata") today announced that...